Activity content starts in:
Industry Webcast
MASH Matters: The importance of early screening and diagnosis in high-risk patientsIndustry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit
The prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH, formerly known as NASH) is increasing. Recognizing patients at risk for MASH is important for early screening and diagnosis.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 9/25/2025
Expiration Date: 9/25/2025
Topics
Faculty
Faculty
Supporters and Partners
Industry Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.